Moleculin Biotech Inc (MBRX)
5.08
+0.05
(+0.99%)
USD |
NASDAQ |
May 17, 16:00
5.08
0.00 (0.00%)
After-Hours: 20:00
Moleculin Biotech Stock Buybacks (Quarterly): 0.00 for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | -3.955M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.07M |
| March 31, 2023 | -0.141M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.001M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -74.68M |
| December 31, 2020 | -5.484M |
| September 30, 2020 | -1.779M |
| June 30, 2020 | -10.01M |
| March 31, 2020 | -5.291M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.052M |
| June 30, 2019 | -13.72M |
| March 31, 2019 | -5.516M |
| December 31, 2018 | -1.756M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -2.069M |
| March 31, 2018 | -8.20M |
| December 31, 2017 | -1.204M |
| September 30, 2017 | -0.407M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -4.46M |
| December 31, 2016 | -0.003M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -8.78M |
| March 31, 2016 | -0.387M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-74.68M
Minimum
Mar 2021
0.001M
Maximum
Dec 2021
-5.759M
Average
-0.026M
Median
Stock Buybacks (Quarterly) Benchmarks
| Merck & Co Inc | 122.00M |
| Lixte Biotechnology Holdings Inc | -- |
| Moderna Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -9.162M |